| Dr Alison E Kirby, MD | |
|
55 W Tietan St, Walla Walla, WA 99362-4445 | |
| (509) 525-3720 | |
| (509) 522-1578 |
| Full Name | Dr Alison E Kirby |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 55 W Tietan St, Walla Walla, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447224571 | NPI | - | NPPES |
| 130274 | Medicaid | OR | |
| 133800 | Other | WA | L&I |
| 8132011 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD00028631 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alison E Kirby, MD 55 W Tietan St, Walla Walla, WA 99362-4445 Ph: (509) 525-3720 | Dr Alison E Kirby, MD 55 W Tietan St, Walla Walla, WA 99362-4445 Ph: (509) 525-3720 |
News Archive
A trio of studies being published today in the journals Science and Cell describes advances toward the development of an HIV vaccine. The three study teams all demonstrated techniques for stimulating animal cells to produce antibodies that either could stop HIV from infecting human cells in the laboratory or had the potential to evolve into such antibodies.
Genzyme Corporation today reported four-year follow-up data from its completed Phase 2 multiple sclerosis (MS) trial showing an estimated 71 percent of alemtuzumab treated patients remain free of clinically-active disease as much as three years after most patients received their last course of the investigational compound. The data were presented at the American Academy of Neurology annual meeting.
A novel test that measures proteins from nerve damage that are deposited in blood and spinal fluid reveals the rate of progression of amyotrophic lateral sclerosis (ALS) in patients, according to researchers from Mayo Clinic's campus in Florida, Emory University and the University of Florida.
The German Institute for Quality and Efficiency in Health Care reinvestigated the benefit of biomarker tests to support the decision for or against adjuvant systemic chemotherapy in certain breast cancer patients, that is, women with primary hormone receptor-positive, HER2/neu-negative breast cancer and 0 to 3 affected lymph nodes.
› Verified 4 days ago
Dr. Jennifer L Bolduc, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 55 W Tietan St, Walla Walla, WA 99362 Phone: 509-525-3720 Fax: 509-522-1578 | |
Timothy Isamu O'connor, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 W Tietan St, Walla Walla, WA 99362 Phone: 509-525-3720 | |
Rebekah Dickman, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 W Tietan St, Walla Walla, WA 99362 Phone: 509-525-3720 Fax: 509-522-1593 | |
Donald K Ashley, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1111 S 2nd Ave, Walla Walla, WA 99362 Phone: 509-522-0100 Fax: 509-527-8010 | |
Kristin Marie Satterfield, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1111 S 2nd Ave, Walla Walla, WA 99362 Phone: 509-527-8152 | |
Trent D. Rogers, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 55 West Tietan Street, Walla Walla, WA 99362 Phone: 509-525-3720 Fax: 509-522-1593 |